Trident® Tritanium™ Acetabular Shell Revision Study

Summary

The purpose of this study is to evaluate a hip implant system used when a previous hip replacement surgery has failed.

Conditions

• Arthroplasty, Replacement, Hip

Interventions

DEVICE

Trident® Tritanium™ Acetabular Shell

Trident® Tritanium™ Acetabular Shell

Sponsors & Collaborators

• Stryker Orthopaedics

  lead INDUSTRY

Principal Investigators

• Arthur Malkani, MD · University of Louisville

• Michael Masini, MD · St Joseph Mercy Hospital

• Daniel Ward, MD · New England Baptist Hospital

• Benjamin Bierbaum, MD · New England Baptist Hospital

• Kirby Hitt, MD · Scott & White Memorial Hospital

• Kenneth Greene, MD · Crystal Clinic

• Jim Kudrna, MD · Illinois Bone & Joint Institute

• Ivan Tomek, MD · Dartmouth-Hitchcock Medical Center

• Stephen Kantor, MD · Dartmouth-Hitchcock Medical Center

• Steven Barnett, MD · Orthopedic Specialty Institute

• Carlos Higuera, MD · The Cleveland Clinic

• Joseph Zuckerman, MD · NYU Hospital for Joint Diseases

• Fredrick Jaffe, MD · NYU Hospital for Joint Diseases

• Stephen Incavo, MD · The Methodist Hospital Research Institute

• Timothy Lovell, MD · Rockwood Clinic

• Sean Scully, MD · Cedars Medical Center

• Amar Ranawat, MD · Hospital for Special Surgery, New York

• Geoffrey Westrich, MD · Hospital for Special Surgery, New York

• R D Heekin, MD · Heekin Institute for Orthopedic Research, Inc.

• Bryce Allen, MD · Scott & White Memorial Hospital

Study Design

Allocation

NA

Purpose

TREATMENT

Masking

NONE

Model

SINGLE_GROUP

Eligibility

Min Age

21 Years

Max Age

85 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2006-11-30

Primary Completion

2016-09-30

Completion

2016-09-30

Countries

• United States

Study Locations